Refine Search
(4)
(28)
(74)
(75)

B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

  • $2,500
  • October 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016’, provides an overview of the B-Cell Non-Hodgkin Lymphoma pipeline landscape.

The report provides comprehensive information on the therapeutics under develo...

Metastatic Breast Cancer - Pipeline Review, H2 2016

  • $2,500
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H2 2016’, provides an overview of the Metastatic Breast Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...

Breast Cancer - Pipeline Review, H2 2016

  • $2,500
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H2 2016’, provides an overview of the Breast Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Breast Cancer, com...

Liver Cancer - Pipeline Review, H2 2016

  • $2,500
  • December 2016
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H2 2016’, provides an overview of the Liver Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Liver Cancer, comple...

Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2018’, provides an overview of the Glioblastoma Multiforme (GBM) pipeline landscape.

The report provides comprehensive information on the therapeutics under dev...

Non-Hodgkin Lymphoma - Pipeline Review, H1 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2018’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Non-...

Ovarian Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2018’, provides an overview of the Ovarian Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Ovarian Cancer, ...

Prostate Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2018’, provides an overview of the Prostate Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Prostate Cance...

Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2018’, provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2018’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

The report p...

Colon Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2018’, provides an overview of the Colon Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Colon Cancer, comple...

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2018’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline landscape.

The report provides comprehensive information on the therapeutics ...

Non-Small Cell Lung Cancer - Pipeline Review, H1 2018

  • $2,500
  • June 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2018’, provides an overview of the Non-Small Cell Lung Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under developm...

Bladder Cancer - Pipeline Review, H1 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2018’, provides an overview of the Bladder Cancer pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Bladder Cancer, ...

Hepatocellular Carcinoma - Pipeline Review, H1 2018

  • $2,500
  • May 2018
Add to Basket Quick View Add to Saved List

Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2018’, provides an overview of the Hepatocellular Carcinoma pipeline landscape.

The report provides comprehensive information on the therapeutics under development ...